Drug Delivery Disposition and Dynamics
Other research themes
Our latest news
The first Australian COVID-19 mRNA vaccine candidate, developed by the Monash Institute of Pharmaceutical Sciences (MIPS), has moved a step closer with production reaching a significant development milestone.
Fairfax masthead Good Weekend has named a group of mRNA vaccine developers including Monash Institute of Pharmaceutical Sciences’ Professor Colin Pouton in its list of Australians Who Mattered in 2021.
A team of researchers led by Associate Professor Angus Johnston has received over $800 000 from the National Health and Medical Research Council to design new delivery systems for RNA.
Funding through the Commonwealth Government’s National Health and Medical Research Council (NHMRC) has been announced, with the Monash Institute of Pharmaceutical Sciences (MIPS) successful in grants totalling close to $3.5 million.
A team of researchers led by the University of Auckland and including Monash University, have received a $5 million grant to better understand the role of lymphatic dysfunction in driving organ failure in acute and critical illnesses which includes
Monash University researchers have shown for the first time that mesenteric (gut) lymphatic dysfunction is a potential cause of and therapeutic target for obesity and insulin resistance.
As part of the launch of National Science Week 2021, Dr Harry Al-Wassiti joined a special panel of some of Australia's leading scientific experts.
An innovative Andrews Labor Government partnership with industry and academia has been extended, with Victorian medical researchers and early-stage medtech entrepreneurs producing results that are changing lives.
Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are leading, or playing an integral role, in a number of projects which have received funding from the Commonwealth Government’s Medical Research Future Fund (MRFF).